Cargando…

An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases

ADAM9 (A disintegrin and a metalloprotease 9) is a membrane-anchored protein that participates in a variety of physiological functions, primarily through the disintegrin domain for adhesion and the metalloprotease domain for ectodomain shedding of a wide variety of cell surface proteins. ADAM9 influ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Cheng-Wei, Huang, Yu-Kai, Kuo, Ting-Ting, Liu, Jing-Pei, Sher, Yuh-Pyng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590139/ https://www.ncbi.nlm.nih.gov/pubmed/33096780 http://dx.doi.org/10.3390/ijms21207790

Ejemplares similares

ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells
por: Sher, Yuh-Pyng, et al.
Publicado: (2014)

ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma
por: Lin, Yu-Sen, et al.
Publicado: (2021)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2017)

ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT
por: Lin, Chen-Yuan, et al.
Publicado: (2017)

Evolution of Vertebrate Adam Genes; Duplication of Testicular Adams from Ancient Adam9/9-like Loci
por: Bahudhanapati, Harinath, et al.
Publicado: (2015)

A disintegrin and metalloproteinase domain 9 facilitates SARS-CoV-2 entry into cells with low ACE2 expression
por: Melano, Ivonne, et al.
Publicado: (2023)

ADAM and ADAMTS Family Proteins and Snake Venom Metalloproteinases: A Structural Overview
por: Takeda, Soichi
Publicado: (2016)

Aberrant expression of ADAM9 in ovarian cancer and its clinical significance
por: Guo, Ting, et al.
Publicado: (2019)

CD9 regulates keratinocyte migration by negatively modulating the sheddase activity of ADAM17
por: Liu, Jie, et al.
Publicado: (2019)

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis
por: Chou, Cheng-Wei, et al.
Publicado: (2019)

A Disintegrin and Metalloprotease (ADAM): Historical Overview of Their Functions
por: Giebeler, Nives, et al.
Publicado: (2016)

Influence of Anoctamin-4 and -9 on ADAM10 and ADAM17 Sheddase Function
por: Leitzke, Sinje, et al.
Publicado: (2022)

Structure, regulatory factors and cancer-related physiological effects of ADAM9
por: Haoyuan, MA, et al.
Publicado: (2020)

Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells
por: Nattmann, Anja, et al.
Publicado: (2020)

Role of ADAM10 and ADAM17 in Regulating CD137 Function
por: Seidel, Jana, et al.
Publicado: (2021)

IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD
por: Li, Danyang, et al.
Publicado: (2022)

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023)

Down-Regulation of NDRG1 Promotes Migration of Cancer Cells during Reoxygenation
por: Lai, Liang-Chuan, et al.
Publicado: (2011)

Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP
por: Sammel, Martin, et al.
Publicado: (2019)

Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids
por: Matthews, Alexandra L., et al.
Publicado: (2017)

Role of ADAM10 and ADAM17 in the Regulation of Keratinocyte Adhesion in Pemphigus Vulgaris
por: Kugelmann, Daniela, et al.
Publicado: (2022)

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9
por: Jia, A Y, et al.
Publicado: (2014)

ADAM9 is present at endothelial cell - cell junctions and regulates monocyte – endothelial transmigration
por: English, William R., et al.
Publicado: (2017)

Overexpression of ADAM9 decreases radiosensitivity of hepatocellular carcinoma cell by activating autophagy
por: Zhu, Lijin, et al.
Publicado: (2021)

Overview of dental imaging equipment industry in Taiwan
por: Cheng, Feng-Chou, et al.
Publicado: (2023)

An ADAM9 mutation in canine cone-rod dystrophy 3 establishes homology with human cone-rod dystrophy 9
por: Goldstein, Orly, et al.
Publicado: (2010)

ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation
por: Cheng, Jing, et al.
Publicado: (2022)

LRP1 shedding in human brain: roles of ADAM10 and ADAM17
por: Liu, Qiang, et al.
Publicado: (2009)

ADAM10 and ADAM17, Major Regulators of Chronic Kidney Disease Induced Atherosclerosis?
por: Maas, Sanne L., et al.
Publicado: (2023)

ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells
por: Li, Ya-qing, et al.
Publicado: (2013)

MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9
por: Hua, Yibo, et al.
Publicado: (2018)

Scramblases as Regulators of Proteolytic ADAM Function
por: Reiss, Karina, et al.
Publicado: (2022)

Aryl Hydrocarbon Receptor Activates NDRG1 Transcription under Hypoxia in Breast Cancer Cells
por: Li, En-Yu, et al.
Publicado: (2016)

Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma
por: Cheng, Wei-Chung, et al.
Publicado: (2021)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

ADAM9: A novel player in vestibular schwannoma pathogenesis
por: Breun, Maria, et al.
Publicado: (2020)

EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma
por: Fan, Chi-Chen, et al.
Publicado: (2017)

Publisher Correction: EFHD2 promotes epithelial-to-mesenchymal transition and correlates with postsurgical recurrence of stage I lung adenocarcinoma
por: Fan, Chi-Chen, et al.
Publicado: (2018)

Adam
Publicado: (1880)

Cannot write session to /tmp/vufind_sessions/sess_7ksarkt6nj0ujn4rh8cs8nmojm